SITC 2023: Preclinical development of LYL119, a ROR1-targete

Phase 1 Trial of LYL797, a ROR1-Targeted CAR T-Cell Therapy Enhanced With Genetic and Epigenetic Reprogramming, in


Advanced Triple-Negative...

Related Keywords

Rochester , New York , United States , South San Francisco , California , Phoenix , Arizona , Georgetown University , District Of Columbia , Washington , Oregon , Fred Hutchinson Cancer Research Center , University Hospital , Memorial Sloan Kettering Cancer Center , Tennessee , Philadelphia , Pennsylvania , Thomas Jefferson University Hospital , Portland , Houston , Texas , San Diego , Seattle , Lubnan Chaudhary , Maryc Lessig , Hirva Mamdani , Jenniferm Specht , Yeonhee Kim , Robertoa Leon Ferre , Michael Hurwitz , Hajime Hiraragi , Yazan Migdady , Usama Gergis , Hemants Murthy , Jonathan Goldman , Los Angeles , Lyell Immunopharma , Madison Fagan , Sarah Fitzsimmons , Davidr Spigel , Brendaj Ernst , Amer Beitinjaneh , Heidih Gillenwater , Helle Jensen , Chul Kim , Roisine Ocearbhail , Saranya Chumsri , Bishwa Ganguly , R Alejandro Sica , Oregon Health Science University Hospital , Sarah Cannon Research Institute , David Geffen School Of Medicine , Lyell Immunopharma Inc , University Of California , Eastern Cooperative Oncology Group , Md Anderson Cancer Center , Memoral Sloan Kettering Cancer Center , Science University Hospital , Fred Hutchinson Cancer Center , Georgetown University Medical Center , Karmanos Cancer Institute , University Of Miami , College Of Wisconsin , Oregon Health , Yale School Of Medicine , Wayne State University , Montefiore Medical Center , Biomax Inc , Boldscience Inc , Us Biomax Inc , Cell Therapy Enhanced With Genetic , Epigenetic Reprogramming , Triple Negative Breast Cancer , Lung Cancer , Erika Hamilton , Babar Bashir , Cannon Research Institute , Tennessee Oncology , Jefferson University Hospital , Hutchinson Cancer Center , Cancer Center , University Medical Center , Cancer Institute , Coral Gables , Geffen School , Medical Center , New Haven , Sloan Kettering Cancer Center , Mayo Clinic , Yale New Haven Hospital , Medical College , Response Evaluation Criteria In Solid Tumors , Markets ,